Advertisement

Extrakranielle Gefäßstenosen im höheren Lebensalter — Möglichkeiten der medikamentösen Therapie

  • H. Werner
  • B. Kark
Conference paper

Zusammenfassung

In der Bundesrepublik erkranken jährlich etwa 250000 Menschen an akuten zerebro-vaskulären Störungen. In der Mortalitätsskala sind zerebrovaskuläre Erkrankungen für etwa 14 % aller Todesfälle verantwortlich und stehen damit an dritter Stelle nach Herz-und Kreislauferkrankungen und malignen Tumoren.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Acheson J, Danta G, Hutchinson EG (1969) Controlled trial of dipyridamole in cerebral vascular disease. Br Med J 1: 614PubMedCrossRefGoogle Scholar
  2. Baker RN, Broward JA, Fang HC er al. (1962) Anticoagulant therapy in cerebral infarction. Neurology 12: 823PubMedGoogle Scholar
  3. Baker RN, Schwartz WS and Rose AS (1966) Transient ischemic strokes: a report of a study of anticoagulant therapy. Neurology 16: 841Google Scholar
  4. Bousser MG, Eschwege E, Haguenau M (1983) Controlled trial of aspirin and dipyridamole in the secondary prevention of athero-thrombotic cerebral ischemia. Stroke 14: 5PubMedCrossRefGoogle Scholar
  5. Buren A and Ygge J (1981) Treatment program and comparison between anticoagulants and platelet aggregation after transient ischemic attacks. Stroke 5: 578Google Scholar
  6. Canadian Cooperative Stroke Study Group (1978) A randomized trial of aspirin and sulfinpyrazo-ne in threatened stroke. N Engl J Med 299: 53CrossRefGoogle Scholar
  7. Candelise L, Landi G, Perrone P et al. (1982) A randomized trial of aspirin and sulfinpyrazone in patients with TIA. Stroke 13: 175PubMedCrossRefGoogle Scholar
  8. Check WA (1982) Der vorhersehbare Krankheitsverlauf bei Patienten mit Schlaganfall und TIA. JAMA (deutsche Ausgabe) 17: 910Google Scholar
  9. Coneally PA, Dyken ML, Futty DE et al. (1978) Cooperative study of hospital frequency and character of transient ischemic attacks. VIII Risk factors. JAMA 240: 742CrossRefGoogle Scholar
  10. Cullen KJ, McCall MG, Stenhouse NS (1979) Changing mortality due to strokes in men following treatment of Busselton hypertensives 1967–77. Int. J Epidem 8: 213CrossRefGoogle Scholar
  11. Dorndorf W, Gänshirt H (1972) Die Klinik der arteriellen zerebralen Gefäßverschlüsse. In: Der Hirnkreislauf. Physiologie, Pathologie, Klinik. Gänshirt H (Hrsg) Georg Thieme StuttgartGoogle Scholar
  12. Dyken ML (1983) Anticoagulant and platelet antiaggregating therapy in stroke and threatened stroke. Neurologic Clinics 1: No. 1: 223PubMedGoogle Scholar
  13. Easton JD and Sherman DG (1980) Management of cerebral embolism of cardiac origin. Stroke 11: 433PubMedCrossRefGoogle Scholar
  14. Effeft S, Merx W, Meyer J, Zeumer H (1983) Koronare und zerebrale Arterienverschlüsse: Wiedereröffnung durch Thrombolytika und Dilatation. Deutsches Ärzteblatt 80: Nr. 36: 25Google Scholar
  15. Fields WS, Lemak NA, Frankowski RF et al (1978) Controlled trial of aspirin in cerebral ischemia. Stroke 9: 309PubMedCrossRefGoogle Scholar
  16. Fields WS, Lemak NA, Frankowski RF et al. (1977) Controlled trial of aspirin in cerebral ischemia. Stroke 8: 301PubMedCrossRefGoogle Scholar
  17. Gryglewski RJ, Nowak S, Kostka-Trabka E et al. (1983) Treatment of ischemie stroke with prostacyclin. Stroke 14: 197PubMedCrossRefGoogle Scholar
  18. Guirau-Chaumeil B, Rascol A, David J et al. (1982) Prévention des récidives des accidents vasculaires cérébraux ischemiques par les anti-aggregants plaquettaires. Rev Neurol 138: 367Google Scholar
  19. Hamann H, Vollmar JF (1983) Operative Möglichkeiten bei extrakraniellen Arterienstenosen. Deutsches Ärzteblatt 80 Nr. 24: 25Google Scholar
  20. Heiss WD (1982) Prophylaxe zerebraler Durchblutungsstörungen. Dtsch med Wschr 107: 1198PubMedCrossRefGoogle Scholar
  21. Hennerici M, Aulich A. Sandmann W and Freund HJ (1981) Incidence of asymptomatic extracranial arterial disease. Stroke 12: 750PubMedCrossRefGoogle Scholar
  22. Heymann A (1980) Risk of stroke in asymptomatic persons with cervial arterial bruits: apopula-tion study in Evans County, Georgia. N Eng J Med 302: 838CrossRefGoogle Scholar
  23. Humphries AW, Young VR, Santelli P et al. (1976) Suspected asymptomatic significant internal carotid stenosis: A review of 182 instances. Surgery 80: 695PubMedGoogle Scholar
  24. Lechner H, Ladurner G, Ott E (1979) Die Karotisinsuffizienz. In: Lechner H, Ladurner G, Ott E (Hrsg) Die zerebralen transitorisch-ischämischen Attacken. Hans Huber, Bern. Stuttgart, Wien.Google Scholar
  25. Leonberg SC and Elliott FA (1981) Prevention of recurrent stroke. Stroke 12: 731PubMedCrossRefGoogle Scholar
  26. Millikan CH and McDowell FH (1981) Treatment of progressing stroke. Stroke 12: 397PubMedCrossRefGoogle Scholar
  27. Mohr JP (1982) Asymptomatic carotid artery disease. Stroke 13: 431PubMedCrossRefGoogle Scholar
  28. Mohr JP (1978) Transient ischémie attacks and the prevention of strokes. N Engl J Med 299: 93PubMedCrossRefGoogle Scholar
  29. Olsson JE, Brechter C, Backlund H et al. (1980) Anticoagulants vs. anti-platelet therapy as prophylactic aganist cerebral infarction in transient ischemie attacks. Stroke 11:4PubMedCrossRefGoogle Scholar
  30. Pearse JMS, Gubbay SS, Walton JN (1965) Long-term anticoagulant therapy in transient cerebral ischemie attacks. Lancet Lancet: 6Google Scholar
  31. Raithel D (1977) Ergebnisse operativer Maßnahmen In: Raithel D (Hrsg) Zerebrale Insuffizienz durch extracranielle Gefäßverschlüsse. Sträube, ErlangenGoogle Scholar
  32. Reuther R und Dorndorf W (1978) Aspirin in patients with cerebral ischemia and normal angiograms or non-surgical lesions: The results of a double blind study. In: Breddin K, Dorndorf W, Loew D et al. (eds) (1978) Acetylsalicylic acid in cerebral ischemia and coronary heart disease. Schattauer, StuttgartGoogle Scholar
  33. Sandok BA, Furlan AJ, Whisnant JP, Sundt TM (1978) Guidelines for the management of transient ischemie attacks. Mayo Clinic Proc 53: 665Google Scholar
  34. Sørenson PS, Pedersen H, Marquardsen J et al. (1983) Acetylsalicylic acid in the prevention of stroke in patients with reversible ischemic attacks. A Danish cooperative study. Stroke 13: 15CrossRefGoogle Scholar
  35. Veterans Administration Cooperative Study Group on Hypertensive Agents (1967, 1970) Effects of treatment on morbidity in Hypertension I and II. J Am med Ass 202: 116 and 213: 1143CrossRefGoogle Scholar
  36. Veterans Cooperative Study of Atherosclerosis, Neurology Section (Report) (1961) An evaluation of anticoagulant therapy in the treatment of cerebral vascular disease. Neurology 11 (part 2): 132Google Scholar
  37. Wolf PA, Kannel WB, Sorlie P (1981) Asymptomatic carotid bruit and the risk of stroke: The Framingham Study JAMA 245: 1442PubMedCrossRefGoogle Scholar
  38. Wolf PA, Kannel WB, Verter J (1983) Current status of risk factors. Neurologic Clinics Current status of risk factors: No. 1: 317Google Scholar
  39. Wylie EJ, Ehrenfeld WK (1970) Extracranial occlusive cerebrovascular disease. Diagnosis and management. Saunders, Philadelphia, London, TorontoGoogle Scholar
  40. Yatsu FM and Hart RG (1983) Asymptomatic carotid bruit and stenosis: A reappraisal. Stroke 14: 301PubMedCrossRefGoogle Scholar
  41. Zeumer H, Ringelstein EB, Hassel M, Poeck K (1983) Lokale Fibrinolyse bei subtotaler Stenose der Arteria cerebri media. Dtsch med Wschr 108: 1103PubMedCrossRefGoogle Scholar

Copyright information

© Dr. Dietrich Steinkopff Verlag, GmbH & Co. KG, Darmstadt 1984

Authors and Affiliations

  • H. Werner
    • 1
  • B. Kark
  1. 1.Städtisches Krankenhaus HöchstFrankfurt a.Main 80Deutschland

Personalised recommendations